The Environment Is a Key Factor in Determining the Anti-Amyloid Efficacy of EGCG

Millions of people around the world suffer from amyloid-related disorders, including Alzheimer’s and Parkinson’s diseases. Despite significant and sustained efforts, there are still no disease-modifying drugs available for the majority of amyloid-related disorders, and the overall failure rate in cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sneideris, Tomas, Sakalauskas, Andrius, Sternke-Hoffmann, Rebecca, Peduzzo, Alessia, Ziaunys, Mantas, Buell, Alexander K., Smirnovas, Vytautas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995563/
https://www.ncbi.nlm.nih.gov/pubmed/31835741
http://dx.doi.org/10.3390/biom9120855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995563/
https://www.ncbi.nlm.nih.gov/pubmed/31835741
http://dx.doi.org/10.3390/biom9120855

Ejemplares similares